Reflexion Pharmaceuticals, Inc. — Form D

Reflexion Pharmaceuticals, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2011-12-01. The offering totals $1.3M, of which $1.1M was reported sold. Industry: Other.

Offering

• Filed: 2011-12-01
• Form: D
• Accession: 0001534808-11-000001
• Industry: Other
• Exemptions: 06
• Total offering: $1.3M
• Amount sold: $1.1M
• Remaining: $106K
• Minimum investment: $10K
• Investors: 12
• Date of first sale: 2011-08-31
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-169481

Issuer

• Name: Reflexion Pharmaceuticals, Inc.
• CIK: 0001534808
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2008
• Address: 201 SANSOME STREET, SAN FRANCISCO, CA, 94104
• Phone: (650) 245-8913

Officers, directors & promoters (19)

More

• CIK 1534808 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search